{"id":"tp-54293","type":"article-newspaper","title":"MaxCyte Agrees to Acquire Akron Bio in $151.8 Million Deal","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54293","datePublished":"2026-11-11T18:00:29.000Z","dateModified":"2026-11-11T18:00:29.000Z","language":"en","abstract":"The proposed transaction includes $105 million in cash, shares valued at about $26.8 million and $20 million in guaranteed deferred payments.","section":"Business","references":[{"title":"earlier preliminary estimate of third-quarter core revenue","url":"https://www.tokenpost.com/news/business/31865"}]}